Clinical Trial Update: Pharmacokinetic-guided Dosing of Emicizumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating pharmacokinetic-guided dosing of emicizumab in people with Hemophilia A (with and without inhibitors) across age groups includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Hemophilia Without Inhibitors
• Hemophilia with Inhibitors

Drugs mentioned

• Emicizumab (emicizumab)

Snippet

Sponsor: Kathelijn Fischer | Conditions: Hemophilia A With Inhibitor, Hemophilia A Without Inhibitor | Phase 4 | Status: RECRUITING